PSD-95 (Post-synaptic density protein 95) Activators belong to a class of chemical compounds that have the capacity to modulate the function or activity of PSD-95, a crucial protein found in the post-synaptic density of neurons. PSD-95 plays an essential role in the organization and stabilization of synaptic structures, particularly at excitatory synapses in the central nervous system (CNS). It belongs to the membrane-associated guanylate kinase (MAGUK) family of proteins, which are scaffold proteins that help anchor neurotransmitter receptors, ion channels, and signaling molecules at the synapse. PSD-95, in particular, is known for its pivotal role in the regulation of synaptic strength, synaptic plasticity, and dendritic spine morphology.
The activation of PSD-95 can have profound effects on synaptic function and neuronal communication. PSD-95 Activators may influence the clustering and anchoring of neurotransmitter receptors and ion channels at the post-synaptic membrane. By modulating PSD-95, these compounds can impact synaptic transmission, synaptic plasticity, and the overall excitability of neurons. This class of chemicals is of great interest in neurobiology research, where precise control over synaptic function and plasticity is essential to understanding the cellular and molecular mechanisms underlying learning, memory, and various neurological disorders.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
N-Methyl-D-Aspartic acid (NMDA) | 6384-92-5 | sc-200458 sc-200458A | 50 mg 250 mg | $107.00 $362.00 | 2 | |
Activation of NMDA receptors can enhance PSD-95 expression, as these receptors play a central role in synaptic plasticity and memory formation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
By binding to its nuclear receptors, retinoic acid can influence the expression of various genes, potentially including PSD-95, especially during neural development. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
cAMP analogs like db-cAMP can activate protein kinase A (PKA), which may lead to enhanced PSD-95 expression as part of broader changes in synaptic protein expression. | ||||||
Ginsenoside Rg1 | 22427-39-0 | sc-205708 sc-205708A | 5 mg 10 mg | $260.00 $476.00 | ||
A major active component of ginseng. Ginsenoside Rg1 can enhance PSD-95 expression, potentially through its neuroprotective and neurotrophic effects. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
An antiepileptic suggested compound that has histone deacetylase inhibitory activity. Valproic acid can influence the expression of various genes, potentially including PSD-95. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Used as a mood stabilizer, lithium can influence various signaling pathways in neurons, potentially affecting PSD-95 expression. | ||||||
Tianeptine | 66981-73-5 | sc-213044 sc-213044A | 10 mg 50 mg | $250.00 $422.00 | ||
An antidepressant known to modulate glutamatergic neurotransmission. Tianeptine might influence PSD-95 expression as part of its effects on synaptic plasticity. | ||||||
Fluoxetine hydrochloride | 56296-78-7 | sc-201125 sc-201125A sc-201125B sc-201125C | 50 mg 250 mg 1 g 5 g | $75.00 $209.00 $399.00 $849.00 | 14 | |
A selective serotonin reuptake inhibitor (SSRI). Chronic treatment with fluoxetine has been shown to influence the expression of synaptic proteins, including PSD-95. | ||||||
D-Cycloserine | 68-41-7 | sc-221470 sc-221470A sc-221470B sc-221470C | 200 mg 1 g 5 g 25 g | $27.00 $75.00 $139.00 $520.00 | 4 | |
A partial NMDA receptor agonist. D-cycloserine might enhance PSD-95 expression through its modulation of NMDA receptor activity. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $107.00 $316.00 | 3 | |
A phosphodiesterase inhibitor. Cilostazol has been shown to upregulate PSD-95 expression, potentially through its effects on cAMP signaling. | ||||||